Helfie AI Appoints Healthcare Leaders Antonin de Fougerolles and Cheryl Buxton to Board of Directors

MELBOURNE, Australia-Helfie AI , a global mobile health platform, has appointed two new members to its Board of Directors. Antonin (Tony) de Fougerolles, a PhD and internationally renowned scientist, will serve as Non-Executive Chairman, while Cheryl Buxton, a global healthcare executive, will serve as an independent non-executive member of the Board of Directors.

Helfie AI is an innovative AI-powered mobile platform that allows anyone with a smartphone to quickly and accurately screen a range of health conditions from anywhere. These appointments herald a critical step in Helfie AI’s mission to revolutionize access to and participation in global healthcare.

George Tomeski, co-founder and CEO of Helfie AI, said, “Having healthcare industry experts like Tony and Cheryl join our board is a significant milestone in the company’s growth. Helfie will put basic, life-saving healthcare checkups in the hands of literally billions of people around the world. As we move toward commercialization of our game-changing technology, we are thrilled to bring Tony and Cheryl on board, who have extensive healthcare experience and deep knowledge of early-stage companies.”

Dr. de Fougerolles served as the founding Chief Scientific Officer of Moderna and most recently as CEO of Evox Therapeutics. In a 25-year career in drug development, he helped build three transformative drug platforms that led to multiple drug approvals in areas such as infectious diseases, cardiology, and rare diseases. He has also helped grow several startups into multi-billion dollar enterprises. Dr. de Fougerolles has extensive experience in operationally scaling companies and will advise Helfie AI on company formation, fundraising, and selecting the right health conditions for Helfie’s technology.

Buxton’s most recent role was as Vice President of Pharmaceuticals and Research & Development at Korn Ferry International, a global organizational consulting firm. Buxton has extensive knowledge of the healthcare industry across a wide range of industries and geographies. Buxton also has deep global experience building high-performance teams for many of the world’s leading healthcare companies and will help Helfie grow into a multinational organization and connect with healthcare industry leaders.

Dr. de Fougerolles said: “Helfie AI is the first company I have seen that has the potential to revolutionize healthcare by making medical checkups easy and accessible to everyone, similar to what Apple has done with music. The ability to identify and screen for health issues early will lead to better patient outcomes. I am excited to dedicate my time and attention to collaborating with the Helfie team on this transformative platform.”

Buxton said: “Helfie’s AI promises to address the imbalance in access to healthcare for people of different socioeconomic backgrounds in different regions of the world. Everyone from a single mother living in a remote area to a time-poor executive in a big city can access basic checkups with Helfie’s technology. The potential to provide a truly equitable approach to preventative healthcare is extremely exciting to me as I join the board.”

Helfie AI’s advanced AI technologies analyze images, videos, audio recordings, or facial scans to check for indications of potential health conditions. Helfie AI generates immediate results and provides the user with information and options on how to proceed. The user owns and controls all data provided as part of the checks.

About Helfie AI

Helfie AI was founded in Melbourne, Australia in 2021 and has expanded its operations to Europe, North America, Africa and Asia with several active B2B partnerships with top-tier companies.

Helfie AI addresses two of the fundamental challenges in healthcare: the lack of preventive healthcare adherence and the underutilization of health data. Every aspect of healthcare, starting with people’s quality of life and longevity, can be significantly improved if everyone actively participates in preventive healthcare and if the related data is actively used throughout the healthcare system.

The level of accessibility enabled by Helfie AI can significantly reduce the $7 trillion annual spending on treating preventable diseases.

Helfie AI provides users with clear guidance on next steps, connects them with medical support services when needed, enables interaction on a variety of health issues from cardiovascular to skin health, and lets them share AI findings with their caregivers and doctors.

Further details on the checks Helfie can perform are available at www.helfie.ai .

The original text of this announcement, written in the source language, is the official version that is authoritative. Translations are offered solely for the convenience of the reader and must refer to the original language text, which is the only legally valid one.